Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/3176 stock hub

TPEX/3176 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/3176is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.6B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/3176

In the news

Latest news · TPEX/3176

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-6.1

P25 -16.2P50 0.3P75 9.8

ROIC-4.8

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/3176 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

TWD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 6.2B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0003176004
Last refreshed	2026-05-10
Market cap	TWD 4.6B
Price	TWD 33.05
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/3176
Website	https://www.medigen.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.36%
EV Earnings	-56.96x
EV/FCF	-200.54x
EV/Sales	3.92x
FCF yield	-0.67%
P/B ratio	0.98x
P/S ratio	2.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9.92%
EBITDA Margin	-0.57%
Gross margin	57.19%
Gross Profit	TWD 905M
Gross Profit Growth	20.07%
Gross Profit Growth Q	13.86%
Gross Profit Growth3 Y	117.91%
Gross Profit Growth5 Y	27.98%
Net Income	TWD -108.8M
Net Income Growth Years	3%
Pretax Margin	-13.81%
Profit Margin	-6.88%
ROA	-1.52
Roa5y	-3.26
ROCE	-2.89
ROE	-6.07
Roe5y	-9.3
ROIC	-4.76
Roic5y	-12.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-5.66%
Cagr15y	1.21%
Cagr1y	12.62%
Cagr20y	9.96%
Cagr3y	-1.89%
Cagr5y	-11.54%
EPS Growth Years	3
FCF Growth Q	-13.25%
OCF Growth	6.93%
OCF Growth Q	-13.11%
OCF Growth10 Y	-17.98%
Revenue Growth	15.28x
Revenue Growth Q	-1.2x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	14.44x
Revenue Growth5 Y	20.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.25
Assets	TWD 6.2B
Cash	TWD 2.5B
Current Assets	TWD 3.5B
Current Liabilities	TWD 744.7M
Debt	TWD 911.3M
Debt EBITDA	TWD 57.31
Debt Equity	TWD 0.19
Debt FCF	TWD -29.49
Equity	TWD 4.7B
Interest Coverage	-6.79
Liabilities	TWD 1.5B
Long Term Assets	TWD 2.7B
Long Term Liabilities	TWD 719.9M
Net Cash	TWD 1.6B
Net Cash By Market Cap	TWD 34.19
Net Cash Growth	1.21%
Net Debt Equity	TWD -0.33
Tangible Book Value	TWD 1.5B
Tangible Book Value Per Share	TWD 10.45
WACC	5.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.68
Inventory Turnover	1.1
Net Working Capital	TWD 473.2M
Quick ratio	3.8
Working Capital	TWD 2.7B
Working Capital Turnover	TWD 0.58

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-44.17%
1Y total return	12.61%
200-day SMA	30.81
3Y total return	-5.57%
50-day SMA	31.61
50-day SMA vs 200-day SMA	50over200
5Y total return	-45.82%
All Time High	486
All Time High Change	-93.2%
All Time High Date	2014-06-13
All Time Low	4.8
All Time Low Change	588.54%
All Time Low Date	2006-03-27
ATR	1.28
Beta	0.28
Beta1y	-0.02
Beta2y	0.38
Ch YTD	2.01
High	34.6
High52	35.95
High52 Date	2026-03-19
High52ch	-8.07%
Low	32.7
Low52	28
Low52 Date	2025-10-14
Low52ch	18.04%
Ma50ch	4.57%
Price vs 200-day SMA	7.27%
RSI	54.63
RSI Monthly	47.75
RSI Weekly	57.07
Sharpe ratio	0.46x
Sortino ratio	0.97
Tr YTD	2.01
Tr15y	19.78%
Tr1m	0.3%
Tr1w	-0.3%
Tr3m	4.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -157M
Operating margin	-9.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	102,842,672%
Net Borrowing	-90,818,000
Shares Insiders	11.12%
Shares Institutions	3.31%
Shares Out	139,306,755
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -61.9M
Average Volume	592,478.55x
Bv Per Share	11.12
CAPEX	TWD -71.4M
Ch10y	-44.17
Ch15y	14.76
Ch1m	0.3
Ch1w	-0.3
Ch1y	12.61
Ch20y	495.5
Ch3m	4.59
Ch3y	-5.57
Ch5y	-45.82
Ch6m	6.61
Change	-0.15%
Change From Open	-1.2
Close	33.1
Days Gap	1.06
Depreciation Amortization	148,045,000
Dollar Volume	13,412,549.3
Earnings Date	2026-05-13
EBIT	TWD -157M
EBITDA	TWD -8.9M
EPS	TWD -0.78
F Score	5
FCF	TWD -30.9M
FCF EV Yield	-0.5x
FCF Per Share	TWD -0.22
Financing CF	-37,804,000
Fiscal Year End	December
Founded	1,990
Goodwill	76,175,000
Income Tax	TWD 77.4M
Investing CF	-66,627,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Ma150	31.01
Ma150ch	6.59%
Ma20	32.11
Ma20ch	2.92%
Net CF	-64,115,000
Next Earnings Date	2026-05-13
Open	33.45
P OCF Ratio	113.6
Position In Range	18.42
Ppne	1,867,243,000
Price Date	2026-05-08
Ptbv Ratio	3.16
Relative Volume	0.69x
Revenue	1,582,503,000x
SBC By Revenue	1.96x
Share Based Comp	31,005,000
Tax By Revenue	4.89x
Tr20y	567.95%
Tr6m	6.61%
Volume	405,826
Z Score	2.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/3176 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/3176 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/3176?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.3%

Share of float held by funds and institutions

Insider ownership

+11.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/3176 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.6

Neutral momentum band

Price vs 200-day MA

+7.3%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/3176

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/3176 stock rating?

tpex/3176 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/3176 analysis?

The full report lives at /stocks/tpex/3176/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/3176?

The latest report frames tpex/3176 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/3176 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.